For the first time, we found that FKBP1A could bind with SLC3A2, and negatively regulated SLC3A2 expression during the processes of everolimus inducing ferroptosis of BC cells and promoting anti-proliferation of Th9 lymphocytes. The gene discussed is FKBP1A; the disease is breast cancer.